HOW OFTEN SHOULD YOU GET A VITAMIN B12 INJECTION
A broad methodological and mechanistic analysis was provided in a critical review discussing thrombin versus factor Xa cleavage: this review emphasizes both the specificity of thrombin at the consensus site and the risk of off-target cleavage in the fusion partner (target protein or POI), urging careful characterization of the final product [150]
Starting July 2026, Wegovy is also one of the three drugs covered under the GLP-1 Bridge program for weight loss at a $50/month copay, manufactured by Novo Nordisk
This matters for a practical reason
As employers design their coverage plans, Huang says they are also increasingly paying close attention to how employees are using the drugs, persistence and discontinuation rates, and outcomes when the drugs are stopped
Stability Enhancers: Some labs use carrier proteins like 0.1% BSA for added stability (depending on application)